Search | IOVS | ARVO Journals

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

View

Showing 1 – 4 of 4

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract September 2016

A Phase 1 Pharmacokinetic Study to Assess the Relative Systemic Bimatoprost Exposure Following Placement of a Novel Bimatoprost Ocular Insert in Healthy Adults

Gary Walker; James E Patrick; Kenneth N Sall; William G Kramer; Robyn L Phelps; Shweta Soni; Melanie Gee-Shihabi; Charles P Semba

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3024.

ARVO Annual Meeting Abstract June 2015

A One-year, Multicenter, Randomized, Double-masked Placebo-controlled Study of Lifitegrast Ophthalmic Solution 5.0% in Patients with Dry Eye: Findings for Subjects Electing to Use Artificial Tears

Kelly K Nichols; Parag A Majmudar; Eric D Donnenfeld; Aparna Raychadhuri; Charles P Semba

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):325.

ARVO Annual Meeting Abstract April 2011

A Phase 2 Multicenter, Double-masked, Placebo-controlled Study Of A Novel Lymphocyte Function-associated Antigen-1 (LFA-1) Antagonist (SAR 1118) For Treatment Of Dry Eye

Charles P. Semba; Gail Torkildsen; John Lonsdale; Eugene McLaurin; Joel Geffin; Thomas Mundorf; Kathryn Kennedy; George Ousler

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):3823.

ARVO Annual Meeting Abstract April 2011

A Phase 1 Clinical Trial of the Safety and Pharmacokinetics of SAR 1118, a Novel Topical LFA-1 Antagonist for Diabetic Macular Edema

Daniel M. Paskowitz; Charles P. Semba; Valerie L. Smith; Tom Gadek; Ovais Shaikh; Quan D. Nguyen; Diana V. Do; Wilmer SAR Study Group

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):570.

Advertisement